Skip to main content
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · CTXR ISIN · US17322U2078 LEI · 5493005C10W36P4KQP40 US Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2011-03-30 Regulatory Filings
Country US United States of America
Listing US CTXR

About Citius Pharmaceuticals, Inc.

https://www.citiuspharma.com/

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).

Recent filings

Filing Released Lang Actions
Regulatory Filings 2011
Regulatory Filings
2011-03-30 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a letter from Trail One, Inc. to the SEC responding to comments on an Amendment No. 2 to a Registration Statement on Form S-1. The content discusses corrections to the registration statement, marketing plans, financing needs, risk factors, and forward-looking statements. It is clearly a correspondence related to a registration statement filing, not a financial report, earnings release, or other report types. The document is not a report itself but a regulatory filing responding to SEC comments on a registration statement. Therefore, it fits best under Regulatory Filings (RNS). The document length is substantial (15,000 characters), but it is correspondence and not a report or announcement of a report publication. Hence, the classification is RNS with high confidence.
2011-03-16 English
TRAIL ONE S-1/A
Capital/Financing Update Classification · 95% confidence The document is a Form S-1/A, Amendment No. 2, which is a registration statement filed with the SEC under the Securities Act of 1933. It is used by companies planning to go public or register securities for resale. The text includes detailed information about the offering, risk factors, management discussion, financial statements, and other disclosures typical of a registration statement. This is not an annual report, earnings release, or any other report type but a capital raising filing. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed substantive information about the offering, not just an announcement or certification. Hence, the classification is CAP with high confidence.
2011-03-16 English
Regulatory Filings 2011
Regulatory Filings
2011-02-03 English
Regulatory Filings 2011
Regulatory Filings Classification · 100% confidence The document is a detailed response letter from TrailOne, Inc. to the SEC regarding comments on their Registration Statement on Form S-1A filed on December 28, 2010. The content includes revisions and clarifications related to disclosures required by Regulation S-K and S-X, descriptions of business operations, risk factors, and corporate governance. It is clearly a correspondence addressing SEC comments on a registration statement, not a financial report, earnings release, or other report type. The document references the Form S-1A registration statement, which is a filing for securities registration, and the letter is a regulatory correspondence. Therefore, this document fits best under Regulatory Filings (RNS) as it is a regulatory response and does not contain financial statements or report data itself.
2011-01-21 English
FORM S-1 AMENDMENT
Capital/Financing Update Classification · 95% confidence The document is a Form S-1/A (Amendment No. 1) registration statement filed with the SEC under the Securities Act of 1933. It is a registration statement for the resale of common stock by a selling security holder. The document includes a preliminary prospectus with detailed information about the company, its business, risk factors, management discussion and analysis, financial statements, and other disclosures typical of a registration statement for an initial or secondary public offering. This type of filing is related to capital raising and securities registration, not an annual report, earnings release, or other financial report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or certification, so it is not RPA or RNS. Confidence is high given the clear identification of the form and content.
2011-01-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.